A Phase 2, Multi-center, Vehicle- and Sham-controlled, Randomized Study of RESTASIS X in Patients With Moderate to Severe Dry Eye Disease

Trial Profile

A Phase 2, Multi-center, Vehicle- and Sham-controlled, Randomized Study of RESTASIS X in Patients With Moderate to Severe Dry Eye Disease

Recruiting
Phase of Trial: Phase II

Latest Information Update: 02 Aug 2017

At a glance

  • Drugs Ciclosporin (Primary)
  • Indications Dry eyes
  • Focus Therapeutic Use
  • Sponsors Allergan
  • Most Recent Events

    • 26 Jul 2017 Planned number of patients changed from 146 to 32.
    • 26 Jul 2017 Planned End Date changed from 1 Jul 2018 to 1 Apr 2019.
    • 26 Jul 2017 Planned primary completion date changed from 1 Jul 2018 to 1 Apr 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top